跳至主要内容
临床试验/ISRCTN29843533
ISRCTN29843533已完成3 期

Determination of which Health Related Quality of Life (HRQoL) instrument is most preferred by patients with early and advanced thyroid cancer

niversity Hospitals Coventry & Warwickshire NHS Trust (UK)0 个研究点目标入组 466 人开始时间: 2011年9月26日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
466

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Patients 18 years old or over
  • 2. Patients attending the thyroid or head neck cancer clinic who are:
  • 2.1. Being treated or undergoing follow-up for differentiated (papillary or follicular) thyroid cancer or
  • 2.2. Being investigated or treated for differentiated (papillary or follicular) thyroid cancer recurrence
  • Note: patients with high grade variants such as insular carcinoma or poorly differentiated carcinoma are eligible
  • 3. Male or female

排除标准

  • 1. Patients who do not sufficiently understand the English language and those with learning disabilities ? as these are standardized and validated questionnaires which are in English
  • 2. Patients who have medullary thyroid cancer or anaplastic thyroid cancer or lymphoma of the thyroid
  • 3. Patients having a diagnostic hemithyroidectomy for possible thyroid cancer

研究者

发起方
niversity Hospitals Coventry & Warwickshire NHS Trust (UK)

相似试验